Compare INSE & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSE | VRCA |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.6M | 88.0M |
| IPO Year | 2014 | 2018 |
| Metric | INSE | VRCA |
|---|---|---|
| Price | $4.50 | $3.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $6.85 | ★ $13.83 |
| AVG Volume (30 Days) | ★ 516.7K | 55.8K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $199,800,000.00 | $35,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.15 | $60.79 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 30.25 | ★ 370.22 |
| 52 Week Low | $3.10 | $3.08 |
| 52 Week High | $9.95 | $9.82 |
| Indicator | INSE | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 53.62 |
| Support Level | $3.20 | $3.30 |
| Resistance Level | $8.42 | $4.17 |
| Average True Range (ATR) | 0.31 | 0.28 |
| MACD | 0.17 | 0.08 |
| Stochastic Oscillator | 88.44 | 89.94 |
Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.